» Articles » PMID: 30728065

Microbiome Dysbiosis is Associated with Disease Duration and Increased Inflammatory Gene Expression in Systemic Sclerosis Skin

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2019 Feb 8
PMID 30728065
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Infectious agents have long been postulated to be disease triggers for systemic sclerosis (SSc), but a definitive link has not been found. Metagenomic analyses of high-throughput data allows for the unbiased identification of potential microbiome pathogens in skin biopsies of SSc patients and allows insight into the relationship with host gene expression.

Methods: We examined skin biopsies from a diverse cohort of 23 SSc patients (including lesional forearm and non-lesional back samples) by RNA-seq. Metagenomic filtering and annotation was performed using the Integrated Metagenomic Sequencing Analysis (IMSA). Associations between microbiome composition and gene expression were analyzed using single-sample gene set enrichment analysis (ssGSEA).

Results: We find the skin of SSc patients exhibits substantial changes in microbial composition relative to controls, characterized by sharp decreases in lipophilic taxa, such as Propionibacterium, combined with increases in a wide range of gram-negative taxa, including Burkholderia, Citrobacter, and Vibrio.

Conclusions: Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression. These data provide a comprehensive portrait of the SSc skin microbiome and its association with local gene expression, which mirrors the molecular changes in lesional skin.

Citing Articles

RAPO Attenuates Dermal and Pulmonary Fibrosis in a Mouse Model of Systemic Sclerosis through Macrophage Modulation and Growth of Short-Chain Fatty Acid Producers.

Park H, Yu D, Hong S, Lee J, Park S, Park M Immune Netw. 2025; 24(6):e41.

PMID: 39801739 PMC: 11711128. DOI: 10.4110/in.2024.24.e41.


Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis.

Vecchiotti D, Clementi L, Cornacchia E, Di Vito Nolfi M, Verzella D, Capece D Cancers (Basel). 2024; 16(18).

PMID: 39335188 PMC: 11430343. DOI: 10.3390/cancers16183215.


Current Approaches to Prevent or Reverse Microbiome Dysbiosis in Chronic Inflammatory Rheumatic Diseases.

Nkeck J, Tchuisseu-Kwangoua A, Pelda A, Tamko W, Hamadjoda S, Essama D Mediterr J Rheumatol. 2024; 35(2):220-233.

PMID: 39211023 PMC: 11350408. DOI: 10.31138/mjr.240224.cap.


Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis.

Jang J, Capaldi E, Smith T, Verma P, Varga J, Ho K Mol Med. 2024; 30(1):128.

PMID: 39180015 PMC: 11344357. DOI: 10.1186/s10020-024-00895-8.


Commensal microbiome dysbiosis elicits interleukin-8 signaling to drive fibrotic skin disease.

Zhang W, Peng Q, Huang X, Huang Q, Zhang Z, Li F PNAS Nexus. 2024; 3(7):pgae273.

PMID: 39081787 PMC: 11287872. DOI: 10.1093/pnasnexus/pgae273.


References
1.
Schmid-Wendtner M, Korting H . The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol. 2006; 19(6):296-302. DOI: 10.1159/000094670. View

2.
Hamamdzic D, Kasman L, LeRoy E . The role of infectious agents in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol. 2002; 14(6):694-8. DOI: 10.1097/00002281-200211000-00011. View

3.
Weyrich L, Dixit S, Farrer A, Cooper A . The skin microbiome: Associations between altered microbial communities and disease. Australas J Dermatol. 2015; 56(4):268-74. DOI: 10.1111/ajd.12253. View

4.
Hinchcliff M, Huang C, Wood T, Mahoney J, Martyanov V, Bhattacharyya S . Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis. J Invest Dermatol. 2013; 133(8):1979-89. PMC: 3714324. DOI: 10.1038/jid.2013.130. View

5.
Saldanha A . Java Treeview--extensible visualization of microarray data. Bioinformatics. 2004; 20(17):3246-8. DOI: 10.1093/bioinformatics/bth349. View